Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard A Fine

Showing results (121-130 of 168) with videos related to

Pageof 17
Sort By:
Neuro-Oncology|March 8, 2011
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03Fabio M Iwamoto, Kathleen R Lamborn, John G Kuhn, et al.
Journal of the National Cancer Institute|July 21, 2011
Effect of brain- and tumor-derived connective tissue growth factor on glioma invasionLincoln A Edwards, Kevin Woolard, Myung Jin Son, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 9, 2007
Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adultsPreetha Rajaraman, Sophia S Wang, Nathaniel Rothman, et al.
Journal of Neuroinflammation|March 5, 2025
Antiretroviral drug therapy does not reduce neuroinflammation in an HIV-1 infection brain organoid modelSamuel Martinez-Meza, Thomas A Premeaux, Stefano M Cirigliano, et al.
Plos One|November 4, 2014
Identification of molecular pathways facilitating glioma cell invasion in situIdo Nevo, Kevin Woolard, Maggie Cam, et al.
Journal for Immunotherapy of Cancer|September 9, 2014
Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cellsRachel E Beard, Zhili Zheng, Kiran H Lagisetty, et al.
Journal of Neuro-Oncology|October 23, 2012
A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806)Brian M Alexander, Meihua Wang, W K Alfred Yung, et al.
Neuro-Oncology|March 5, 2010
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)Fabio M Iwamoto, Kathleen R Lamborn, H Ian Robins, et al.
Cancer Research|March 23, 2005
Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferationBenjamin W Purow, Raqeeb M Haque, Martha W Noel, et al.
Neuro-Oncology|February 24, 2009
Occupational exposure to magnetic fields and the risk of brain tumorsJoseph B Coble, Mustafa Dosemeci, Patricia A Stewart, et al.
Pageof 17

Showing results (121-130 of 168) with videos related to

Sort By:
Pageof 17
Neuro-Oncology|March 8, 2011
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03Fabio M Iwamoto, Kathleen R Lamborn, John G Kuhn, et al.
Journal of the National Cancer Institute|July 21, 2011
Effect of brain- and tumor-derived connective tissue growth factor on glioma invasionLincoln A Edwards, Kevin Woolard, Myung Jin Son, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 9, 2007
Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adultsPreetha Rajaraman, Sophia S Wang, Nathaniel Rothman, et al.
Journal of Neuroinflammation|March 5, 2025
Antiretroviral drug therapy does not reduce neuroinflammation in an HIV-1 infection brain organoid modelSamuel Martinez-Meza, Thomas A Premeaux, Stefano M Cirigliano, et al.
Plos One|November 4, 2014
Identification of molecular pathways facilitating glioma cell invasion in situIdo Nevo, Kevin Woolard, Maggie Cam, et al.
Journal for Immunotherapy of Cancer|September 9, 2014
Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cellsRachel E Beard, Zhili Zheng, Kiran H Lagisetty, et al.
Journal of Neuro-Oncology|October 23, 2012
A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806)Brian M Alexander, Meihua Wang, W K Alfred Yung, et al.
Neuro-Oncology|March 5, 2010
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)Fabio M Iwamoto, Kathleen R Lamborn, H Ian Robins, et al.
Cancer Research|March 23, 2005
Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferationBenjamin W Purow, Raqeeb M Haque, Martha W Noel, et al.
Neuro-Oncology|February 24, 2009
Occupational exposure to magnetic fields and the risk of brain tumorsJoseph B Coble, Mustafa Dosemeci, Patricia A Stewart, et al.
Pageof 17